Khandan Baradaran

Nanoscope Therapeutics Appoints SVP of Regulatory and Quality

by | May 17, 2024
Khandan Baradaran, PhD, was most recently VP of regulatory CMC at Ultragenyx Pharmaceutical, a biopharmaceutical company involved in the research and development of novel products for the treatment of rare and ultra-rare genetic diseases.
MORE